| Product Code: ETC067002 | Publication Date: Aug 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Non-Oncology Precision Medicine Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 South Korea Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 South Korea Non-Oncology Precision Medicine Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 South Korea Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 South Korea Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-oncology diseases in South Korea |
4.2.2 Technological advancements in precision medicine |
4.2.3 Growing demand for personalized treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for precision medicine |
4.3.2 High costs associated with precision medicine treatments |
4.3.3 Limited reimbursement options for precision medicine therapies |
5 South Korea Non-Oncology Precision Medicine Market Trends |
6 South Korea Non-Oncology Precision Medicine Market, By Types |
6.1 South Korea Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2027F |
6.1.3 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2027F |
6.1.4 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2027F |
6.1.5 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2027F |
6.1.6 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.1.7 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 South Korea Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2027F |
6.2.3 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2027F |
6.2.4 South Korea Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2027F |
7 South Korea Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 South Korea Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 South Korea Non-Oncology Precision Medicine Market Imports from Major Countries |
8 South Korea Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Adoption rate of precision medicine in non-oncology diseases |
8.2 Number of clinical trials focused on non-oncology precision medicine in South Korea |
8.3 Patient satisfaction and outcomes with precision medicine treatments |
8.4 Investment in research and development of new precision medicine therapies |
8.5 Collaboration and partnerships between healthcare providers and precision medicine companies |
9 South Korea Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 South Korea Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 South Korea Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 South Korea Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 South Korea Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2021 |
10.2 South Korea Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here